Several kinase inhibitors of PI3K/AKT44, TCR45, MEK46, and JAK-STAT47 pathways have been used previously tested in combination with GCs in both B- and T-ALL, consistent with previous reports regarding the cross-talk between BCR pathway signaling and other pathways in B cells48,49. Here, BCR is linked to acute lymphoblastic leukemia.